Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone
Authors:
- Y. ChrétienYCY. Chrétien
- D. WendumDWD. Wendum
- 1 April 2010
- journal article
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 34 (4-5) , 283-287
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisHepatology, 2008
- Budesonide in previously untreated autoimmune hepatitisLiver International, 2005
- Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosisHepatology, 2005
- A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: Ten-year resultsHepatology, 2004
- Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acidHepatology, 2000
- Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled studyJournal of Hepatology, 1998
- A Randomized Trial Comparing Colchicine and Ursodeoxycholic Acid Combination to Ursodeoxycholic Acid in Primary Biliary CirrhosisHepatology, 1996
- Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosisJournal of Hepatology, 1996
- Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid aloneJournal of Hepatology, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992